Skip to main content

Gastroenterology

  • Entecavir prevents hep B reactivation when starting chemo

    Researchers suggest that patients with chronic hepatitis B virus (HBV) infection who must undergo cancer chemotherapy may avoid reactivation of HBV if they receive prophylaxis with entecavir (Baraclude). If HBV is reactivated because of chemotherapy-related immunosuppression, the patient’s treatment may be complicated by subsequent liver damage, hence the need to keep the virus in check.
  • Bisphosphonates linked to lower colorectal cancer risk

    Men and women who have been treated with bisphosphonates to protect against deteriorating bone health also appear to have a reduced risk of developing colorectal cancer, say researchers who explored data from the Manitoba Cancer Registry.
  • Vitamin D deficiency common among IBD patients

    Even in sunshine-rich Florida, vitamin D deficiency was frequently observed among patients diagnosed with inflammatory bowel disease (IBD), researchers reported at the Digestive Disease Week meeting here.
  • Colonoscopy appears safe even with aspirin aboard

    CHICAGO | Patients who are scheduled for colonoscopy or polypectomy are often advised to suspend ASA and/or non-steroidal anti-inflammatory drug (NSAID) therapy to reduce the risk of bleeding, but new research presented here suggests that might not be necessary.
  • Taro recalls one lot of Docusate Sodium

    Notice due to possible bacterial contamination with Cronobacter (Enterobacter) sakazakii.
  • Out with gout

    An update on managing acute attacks and using preventive therapies.
  • Eosinophilic Esophagitis

    Eosinophilic esophagitis (EE) has emerged as a “new” inflammatory condition of note, one that has been diagnosed with increased frequency in both children and adults throughout the world.
  • FOBT: Farewell forthcoming?

    Urine test for colon polyps may also be applied to other conditions, Canadian researchers say
X
This ad will auto-close in 10 seconds